Author: Vonck, Kristl; Garrez, Ieme; De Herdt, Veerle; Hemelsoet, Dimitri; Laureys, Guy; Raedt, Robrecht; Boon, Paul
Title: Neurological manifestations and neuroâ€invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2 Cord-id: dx1n8jap Document date: 2020_5_16
ID: dx1n8jap
Snippet: INTRODUCTION: Infections with coronaviruses are not always confined to the respiratory tract and various neurological manifestations have been reported. The aim of this study was to perform a review to describe neurological manifestations in patients with COVIDâ€19 and possible neuroâ€invasive mechanisms of Sarsâ€CoVâ€2. METHODS: Pubmed, WebOfScience and Covidâ€dedicated databases were searched for the combination of COVIDâ€19 terminology and neurology terminology up to May 10(th) 2020. So
Document: INTRODUCTION: Infections with coronaviruses are not always confined to the respiratory tract and various neurological manifestations have been reported. The aim of this study was to perform a review to describe neurological manifestations in patients with COVIDâ€19 and possible neuroâ€invasive mechanisms of Sarsâ€CoVâ€2. METHODS: Pubmed, WebOfScience and Covidâ€dedicated databases were searched for the combination of COVIDâ€19 terminology and neurology terminology up to May 10(th) 2020. Social media channels were followedâ€up between March 15(th) and May 10(th) 2020 for postings with the same scope. Neurological manifestations were extracted from the identified manuscripts and combined to provide a useful summary for the neurologist in clinical practice. RESULTS: Neurological manifestations potentially related to COVIDâ€19 have been reported in large studies, case series and case reports and include acute cerebrovascular diseases, impaired consciousness, cranial nerve manifestations and autoâ€immune disorders such as Guillainâ€Barré Syndrome often present in patients with more severe COVIDâ€19. Cranial nerve symptoms such as olfactory and gustatory dysfunctions are highly prevalent in patients with mildâ€toâ€moderate COVIDâ€19 even without associated nasal symptoms and often present in an early stage of the disease. CONCLUSION: Physicians should be aware of the neurological manifestations in patients with COVIDâ€19, especially when rapid clinical deterioration occurs. The neurological symptoms in COVIDâ€19 patients may be due to direct viral neurological injury or indirect neuroinflammatory and autoimmune mechanisms. No antiviral treatments against the virus or vaccines for its prevention are available and the longâ€term consequences of the infection on human health remain uncertain especially with regards to the neurological system.
Search related documents:
Co phrase search for related documents- abnormal finding and acute ards respiratory distress syndrome: 1
- abnormal finding and acute illness: 1, 2
- acute ards and additional risk: 1, 2, 3, 4, 5, 6
- acute ards and lumbar puncture: 1, 2
- acute ards respiratory distress syndrome and additional risk: 1, 2, 3, 4, 5, 6
- acute ards respiratory distress syndrome and lumbar puncture: 1, 2
- acute necrotizing encephalopathy and lumbar puncture: 1
Co phrase search for related documents, hyperlinks ordered by date